Evaluation of Serum Level of Soluble Suppressor Tumourginicity 2 (sST2) in Pregnancies Complicated by Preeclampsia | ||||
Benha Journal of Applied Sciences | ||||
Article 23, Volume 5, Issue 7 part (1) - (2), October 2020, Page 137-139 PDF (862.08 K) | ||||
Document Type: Original Research Papers | ||||
DOI: 10.21608/bjas.2020.137317 | ||||
View on SCiNiTO | ||||
Authors | ||||
N.A. Abdel Hafeez1; O.S. El-Shimi1; H.E. Raziq2; M.Y. Mikhael1 | ||||
1Clinical & Chemical Pathology Dept., Faculty of Medicine, Benha Univ., Benha, Egypt | ||||
2Gynecology & Obstetrics Dept., Faculty of Medicine, Benha Univ., Benha, Egypt | ||||
Abstract | ||||
Toxemia (PE) is characterized as new-beginning hypertension and proteinuria or opposite end-organ harm (counting hepatic, renal, hematological, or neurological intricacies) happening following 20 weeks of pregnancy or fetal development limitation. Point and goals : The point of this investigation was to evaluate the serum level of solvent silencer tumorginicty 2 (sST2) in pregnant ladies convoluted with toxemia contrasting and evidently solid pregnant ladies. Techniques: Eighty ladies took care of Benha University Hospitals were isolated into two gatherings; Group (I): Fourty toxemia tolerant , Group (II): Fourty solid subjects as control. Results: Serum sST2 was essentially higher in toxemia cases instead of the obviously solid pregnant controls (P <0.001). End : sST2 might be helpful in conclusion of ladies compilicated by toxemia. | ||||
Keywords | ||||
Preeclampsia (PE); Soluble suppressor tumourginicity 2 (sST2) | ||||
Statistics Article View: 93 PDF Download: 286 |
||||